Alireza Katouzian, MD
Pain Medicine · Camarillo, CANPI 1285665224
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 445 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $5,861 and has fallen 69.6% since, to $1,781 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 445 payments — averaging $41.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik NRO, Inc.$4K
- Abbott$3K
- Medtronic$2K
- Nevro Corp.$2K
- AbbVie$1K
- Saluda Medical Americas, Inc.$926
- plus $5K from 26 others
What the payments were for
- Travel & lodging$330%
- Food & beverage$18,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik NRO, Inc. | 130 | $4,213 |
| Abbott | 69 | $3,077 |
| Medtronic(2 entities) | 59 | $2,491 |
| Nevro Corp. | 27 | $1,705 |
| AbbVie(2 entities) | 67 | $1,185 |
| Saluda Medical Americas, Inc. | 12 | $926 |
| Foundation Fusion Solutions, LLC | 5 | $635 |
| Relievant Medsystems, Inc. | 9 | $580 |
| SPR Therapeutics, Inc | 7 | $572 |
| Boston Scientific | 18 | $536 |
| Vertos Medical, Inc. | 3 | $362 |
| MML US, Inc. | 1 | $341 |
| Painteq LLC | 7 | $339 |
| Amgen(2 entities) | 4 | $277 |
| Vertiflex, Inc. | 2 | $189 |
| Teva Pharmaceuticals USA, Inc. | 2 | $146 |
| Merck | 1 | $125 |
| Vertex | 1 | $123 |
| Biohaven Pharmaceuticals, Inc. | 1 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $116 |
| Lilly USA, LLC | 3 | $109 |
| Stimwave Technologies Incorporated | 1 | $93 |
| Lundbeck LLC | 2 | $50 |
| Stryker | 1 | $47 |
| Arbor Pharmaceuticals, Inc. | 2 | $42 |
| GRT US Holding, Inc. | 2 | $37 |
| Forte Bio-pharma LLC | 2 | $29 |
| Camber Spine Technologies LLC | 1 | $28 |
| Almatica Pharma LLC | 1 | $26 |
| Nalu Medical, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $17 |
| Zyla Life Sciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prospera$1,270
- Intracept$1,218
- Proclaim Family of SCS IPGs$1,134
- Evoke$739
- Senza Spinal Cord Stimulation System$523
- PROCLAIM$477
- SPRINT PNS System$414
- Accurian$364
- ReActiv8$341
- Omnia$339
- mild Device Kit$278
- BIOTRONIK$244
- AIMOVIG$241
- VANTA ADAPTIVESTIM$200
- Penta SCS Leads$175
- Proclaim IPG$154
- Senza$136
- BRIDION$125
- PAINTEQ$124
- AJOVY$121
How this compares
$18,568 in reported general payments places this provider in the 90th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Potassium | 13 | $9,943 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 187 | $4,963 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 187 | $3,907 |
| Buprenorphine | 12 | $3,147 |
| Pregabalin | 71 | $1,525 |
| Naloxone Hcl | 29 | $1,521 |
| Gabapentin | 145 | $1,457 |
| Lidocaine | 23 | $1,399 |
| Oxycodone Hcl | 46 | $1,215 |
| Morphine Sulfate ErMorphine Sulfate | 32 | $731 |
| Tizanidine Hcl | 26 | $433 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 19 | $343 |
| Duloxetine Hcl | 23 | $332 |
| Cyclobenzaprine Hcl | 32 | $269 |
| Celecoxib | 23 | $203 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Camarillo
- Caitlin TourjeCamarillo$80K
- Farid KiaCamarillo$65K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.